World's Best Scientists 2026 revealed!
Peter W Angus

Peter W Angus

D-Index & Metrics

Medicine

D-Index
72
Citations
19705
World Ranking
19823
National Ranking
672

Overview

Peter W Angus is affiliated with the Austin Hospital in Australia and conducts research primarily in the field of Medicine, with a focus on Hepatology. Their work spans several subfields including Hepatology, Epidemiology, Surgery, Cardiology and Cardiovascular Medicine, and Pulmonary and Respiratory Medicine.

The research topics covered by Peter W Angus include:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Diseases and Immunity
  • Organ Transplantation Techniques and Outcomes
  • Gallbladder and Bile Duct Disorders

Their recent notable papers include:

  • "Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials", 2020, Journal of Hepatology
  • "Cirrhotic portal hypertension: From pathophysiology to novel therapeutics", 2020, World Journal of Gastroenterology
  • "Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options", 2021, Journal of Clinical Medicine
  • "Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant", 2022, Clinical Nutrition ESPEN
  • "Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels", 2022, Alimentary Pharmacology & Therapeutics

Frequent co-authors collaborating with Peter W Angus are:

  • Paul Gow
  • Chandana B. Herath
  • Marie Sinclair
  • Amanda Nicoll
  • Lakmie S. Gunarathne

Peter W Angus publishes regularly in several journals, with multiple publications in:

  • Journal of Hepatology
  • International Journal of Epidemiology
  • Alimentary Pharmacology & Therapeutics
  • Journal of Clinical Medicine
  • Hepatology Communications

Best Publications

  • The role of the gut microbiota in NAFLD

    Christopher Leung;Leni Rivera;John B. Furness;Peter W. Angus;Peter W. Angus

  • Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

    Peter W Angus;Rhys B Vaughan;Shelly Xiong;Huiling Yang

  • Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

    D J Tenney;S M Levine;R E Rose;A W Walsh

  • Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Michael Manns;Didier Samuel;Edward J Gane;David Mutimer

  • Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

    Edward J Gane;Stuart K Roberts;Catherine A M Stedman;Peter W Angus

  • Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2

    G Paizis;Christos Tikellis;M E Cooper;J M Schembri

  • Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions

    M. Sinclair;M. Sinclair;P. J. Gow;P. J. Gow;M. Grossmann;M. Grossmann;P. W. Angus;P. W. Angus

  • Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B

    Peter W. Angus;Geoffrey W. McCaughan;Edward J. Gane;Darryl H.G. Crawford

  • Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.

    Eugene Schiff;Cjing Lung Lai;Stephanos Hadziyannis;Peter Nuehaus

  • Diagnosis of Wilson's disease: an experience over three decades

    P J Gow;R A Smallwood;P W Angus;A L Smith

  • Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)

    Vincent Leroy;Peter W Angus;Jean-Pierre Bronowicki;Gregory J Dore

  • Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

    Edward J. Gane;Peter W. Angus;Simone Strasser;Darrell H.G. Crawford

  • Up-regulation of components of the renin-angiotensin system in the bile duct–ligated rat liver

    Georgina Paizis;Mark E. Cooper;Josefa M. Schembri;Christos Tikellis

  • Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial

    Marie Sinclair;Mathis Grossmann;Rudolf Hoermann;Peter W. Angus

  • Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.

    Scott Patterson;Jacob George;Simone Strasser;Alice Lee

  • Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis.

    Georgina Paizis;Richard E Gilbert;Mark E Cooper;Padma Murthi

  • Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.

    Bronwyn A L Crawford;Cherie Kam;Julie Pavlovic;Karen Byth

  • Hepatitis B and C virus infections and anti-tumor necrosis factor-α therapy: Guidelines for clinical approach

    Debbie Michelle Nathan;Peter W Angus;Peter Raymond Gibson

  • Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

    Thein Thein Aye;Angeline Bartholomeusz;Tim Shaw;Scott Bowden

  • Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

    Nancy Reau;Paul Y Kwo;Susan Rhee;Robert S Brown

Frequent Co-Authors

Stephen Locarnini
Stephen Locarnini Melbourne Health
Geoffrey W. McCaughan
Geoffrey W. McCaughan University of Sydney
Alexander J. Thompson
Alexander J. Thompson Ascension Health
Josephine M. Forbes
Josephine M. Forbes University of Queensland
Rinaldo Bellomo
Rinaldo Bellomo Monash University
Edward Gane
Edward Gane Auckland City Hospital
Joseph Torresi
Joseph Torresi University of Melbourne
Darrell H. G. Crawford
Darrell H. G. Crawford University of Queensland
Charles G. Mullighan
Charles G. Mullighan St. Jude Children's Research Hospital
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA opens doors to various online degree programs and career paths beyond the traditional MD. For those interested in leadership roles, pursuing the cheapest mha programs offers a cost-effective route to a Master’s in Healthcare Administration, preparing graduates for management positions in hospitals and healthcare organizations.

Nurses aiming to advance their clinical expertise may consider the least expensive dnp programs. Earning a Doctor of Nursing Practice online provides flexibility while equipping professionals for top clinical and leadership roles.

If your interest lies in medication and patient care, pharmacy school online allows students to pursue a Doctorate in Pharmacy remotely. This pathway can lead to diverse positions in pharmacies, hospitals, and research.

For those passionate about technology and data, an online health information management degree can launch a rewarding career aggregating, safeguarding, and analyzing patient information.

Considering these affordable and flexible online programs can help you tailor your studies to your career ambitions while managing costs effectively.

Best Scientists Citing Peter W Angus

Trending Scientists